Cargando…

Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?

Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclinical data and negative clinical trials using conventional fractionated radiotherapy. However, there is emerging evidence that radiotherapy delivered in few fractions with high single-fraction and total...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rühle, Alexander, Andratschke, Nicolaus, Siva, Shankar, Guckenberger, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630187/ https://www.ncbi.nlm.nih.gov/pubmed/31341985 http://dx.doi.org/10.1016/j.ctro.2019.04.012

Ejemplares similares

Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease
por: Willmann, Jonas, et al.
Publicado: (2022)

Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
por: Wujanto, Caryn, et al.
Publicado: (2019)

Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016)

Intratumoural renal cell carcinoma haemorrhage following stereotactic radiotherapy: a case report
por: Hilleary, Liam A., et al.
Publicado: (2019)

Definition of stereotactic body radiotherapy: Principles and practice for the treatment of stage I non-small cell lung cancer
por: Guckenberger, M., et al.
Publicado: (2013)

Radiotherapy for glioblastoma patients with poor performance status
por: Schröder, Christina, et al.
Publicado: (2021)

In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)
por: John, Caroline, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy
por: Schröder, Christina, et al.
Publicado: (2019)

Single-institution analysis of the prevalence, indications and outcomes of end-of-life radiotherapy
por: Christ, Sebastian M., et al.
Publicado: (2021)

The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma
por: Barbour, Andrew B., et al.
Publicado: (2023)

Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial
por: Kirste, Simon, et al.
Publicado: (2022)

Stereotactic Ablative Radiotherapy for the Treatment of Clinically Localized Renal Cell Carcinoma
por: Campbell, Scott P., et al.
Publicado: (2015)

Stereotactic Radiotherapy in the Treatment of Paraneoplastic Vasculitis in Oligometastatic Renal Cell Carcinoma
por: Burgess, Laura, et al.
Publicado: (2021)

Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma
por: Yamamoto, Takaya, et al.
Publicado: (2016)

Validation and extension of the METSSS score in a metastatic cancer patient cohort after palliative radiotherapy within the last phase of life
por: Christ, Sebastian M., et al.
Publicado: (2022)

Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma
por: Reynolds, Hayley M., et al.
Publicado: (2018)

Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity
por: Fritz, Corinna, et al.
Publicado: (2018)

Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
por: Tran, Kevin T., et al.
Publicado: (2023)

Stereotactic Body Radiotherapy for the Treatment of Renal Tumors()
por: Hanzly, Michael, et al.
Publicado: (2014)

Head and neck radiotherapy on the MR linac: a multicenter planning challenge amongst MRIdian platform users
por: Chamberlain, Madalyne, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy for Primary Prostate Cancer
por: Kothari, Gargi, et al.
Publicado: (2018)

Synthetic computed tomography for low-field magnetic resonance-guided radiotherapy in the abdomen
por: Lapaeva, Mariia, et al.
Publicado: (2022)

Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery
por: Guckenberger, Matthias, et al.
Publicado: (2020)

Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research
por: Vlaskou Badra, Eugenia, et al.
Publicado: (2021)

Neuroendocrine Carcinoma of Uterine Cervix: Stereotactic Radiotherapy for Brain Metastasis and Stereotactic Body Radiotherapy for Renal and Pancreatic Metastases
por: Mori, Yoshimasa, et al.
Publicado: (2020)

Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens
por: Siva, Shankar, et al.
Publicado: (2016)

Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function
por: Senger, C., et al.
Publicado: (2019)

Patient-specific quality assurance strategies for synthetic computed tomography in magnetic resonance-only radiotherapy of the abdomen
por: Dal Bello, Riccardo, et al.
Publicado: (2023)

NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial
por: Ali, Muhammad, et al.
Publicado: (2023)

Dose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer
por: Okoye, Christian C., et al.
Publicado: (2020)

Stereotactic radiation therapy for liver metastases: factors affecting local control and survival
por: Andratschke, Nicolaus HJ, et al.
Publicado: (2015)

Intra- and inter-fraction breath-hold variations and margins for radiotherapy of abdominal targets
por: Ehrbar, Stefanie, et al.
Publicado: (2023)

Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions
por: Jumeau, Raphael, et al.
Publicado: (2020)

A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer
por: Nieder, Carsten, et al.
Publicado: (2012)

Complications from Stereotactic Body Radiotherapy for Lung Cancer
por: Kang, Kylie H., et al.
Publicado: (2015)

Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer
por: Britschgi, Christian, et al.
Publicado: (2018)

Dose escalation for stereotactic arrhythmia radioablation of recurrent ventricular tachyarrhythmia - a phase II clinical trial
por: Kovacs, Boldizsar, et al.
Publicado: (2023)

Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial (99m)Tc-DMSA SPECT/CT
por: Jackson, Price, et al.
Publicado: (2014)

Improved plan quality with automated radiotherapy planning for whole brain with hippocampus sparing: a comparison to the RTOG 0933 trial
por: Krayenbuehl, J., et al.
Publicado: (2017)

Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy: The Next Step in the Treatment of Renal Cell Carcinoma
por: Keller, Brian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ao2jbf08of5blj8dvie5sor2ja